These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 14736838)

  • 41. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
    Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
    Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coincidence imaging using 2 dual-head gamma-camera systems, with and without attenuation correction.
    Even-Sapir E; Yuzefovich B; Miller E; Bouhnik JP; Zak O; Lerman H; Lievshitz G; Levin C
    J Nucl Med Technol; 2004 Dec; 32(4):190-7. PubMed ID: 15576340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staging and follow-up of gastrointestinal tumors with PET/CT.
    Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H
    Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
    Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
    Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
    Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
    Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
    Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma.
    Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
    J Nucl Med; 2012 Aug; 53(8):1244-52. PubMed ID: 22782313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical utility of PET/CT in lymphoma.
    Cronin CG; Swords R; Truong MT; Viswanathan C; Rohren E; Giles FJ; O'Dwyer M; Bruzzi JF
    AJR Am J Roentgenol; 2010 Jan; 194(1):W91-W103. PubMed ID: 20028897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis.
    Chen CJ; Chao TB; Shih DF
    Clin Nucl Med; 2010 Apr; 35(4):258-9. PubMed ID: 20305415
    [No Abstract]   [Full Text] [Related]  

  • 51. The clinical role of CT/PET in oncology: an update.
    Francis IR; Brown RK; Avram AM
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S68-75. PubMed ID: 16361139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission and computed X-ray tomography: a coming together.
    Costa DC; Visvikis D; Crosdale I; Pigden I; Townsend C; Bomanji J; Prvulovich E; Lonn A; Ell PJ
    Nucl Med Commun; 2003 Apr; 24(4):351-8. PubMed ID: 12673162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care.
    Israel O; Kuten A
    J Nucl Med; 2007 Jan; 48 Suppl 1():28S-35S. PubMed ID: 17204718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Positron emission tomography for the preoperative staging of esophageal carcinoma].
    Junginger T; Kneist W; Schreckenberger M; Menzel C; Oberholzer K; Bartenstein P
    Dtsch Med Wochenschr; 2002 Sep; 127(38):1935-41. PubMed ID: 12239652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
    Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of FDG-PET imaging in the management of lymphoma.
    Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT.
    Wahl RL
    J Nucl Med; 2004 Jan; 45 Suppl 1():82S-95S. PubMed ID: 14736839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct comparison of FDG PET and CT findings in patients with lymphoma: initial experience.
    Tatsumi M; Cohade C; Nakamoto Y; Fishman EK; Wahl RL
    Radiology; 2005 Dec; 237(3):1038-45. PubMed ID: 16304117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
    Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM
    Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.